Onychomycosis: Strategies to Reduce Failure and Recurrence

Cutis

Volumn 62, Issue 4, 2000, Pages 189-191

  Gupta, Aditya K ^a,c   Daniel III, C Ralph ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; HUMAN; MALE; ONYCHOMYCOSIS; PATIENT EDUCATION; RECURRENT DISEASE; SKIN DISEASE; TREATMENT FAILURE;

ADULT; AGED; FOOT DERMATOSES; HUMANS; MALE; ONYCHOMYCOSIS; PATIENT EDUCATION; RECURRENCE; TREATMENT FAILURE;

EID: 0032186170     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gupta AK, Scher RK, DeDoncker P. Current management of onychomycosis. An overview. Dermatol Clin 15: 121-135, 1997.
2. Daniel CM, Daniel MP, Daniel CR III: Onychomycosis update. J Miss State Med Assoc 36: 37-39, 1995.
3. Gupta AK, Lynde CW, Raboobee N, et al: Treatment of onychomycosis with terbinafine. In preparation.
4. Baran R, DeDoncker P, Ginter G, et al: Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals. Acta Derm Venereal 76: 82-83, 1996.
5. André J, DeDoncker P, Ginter G, et al: Intermittent pulse therapy in onychomycosis: an update. Poster presented at the 54th Annual Meeting of the American Academy of Dermatology. Washington, DC, February 10-15, 1996.
6. Gupta AK, Daniel CR: Factors that may affect the response of onychomycosis to oral antifungal therapy. Australas J Dermatol (in press).
7. Roberts DT, Evans EGV: Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol 138: 189-190, 1998.
8. Baran R, Hay RJ: Partial surgical avulsion of the nail in onychomycosis. Clin Exp Dermatol 10: 413-418, 1985.
9. Gupta AK, Del Rosso JQ, Daniel CR: All abnormal nails are not the result of a dermatophyte infection; clinical judgment alone is no substitute for confirmation of diagnosis by mycological examination. Poster presented at the Meeting of the American Academy of Dermatology. New York, July 30-August 3, 1997.
10. Elewski BE: Bacterial infection in a patient with onychomycosis. J Am Acad Dermatol 37: 493-494, 1997.
11. Elewski BE, Charif MA, Daniel CR: Onychomycosis. In, Nails: Therapy, Diagnosis, Surgery, 2nd ed (Scher RK, Daniel CR, eds), p 151. Philadelphia, WB Saunders, 1997.
12. DeDoncker P, Decroix J, Piérard GE, et al: Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of one-week pulse therapy with itraconazole. Arch Dermatol 132: 3441, 1996.
13. Schatz F, Bräutigam M, Dobrowolski E, et al: Nail incorporation kinetics of terbinafine in onychomycosis patients. Clin Exp Dermatol 20: 377-383, 1995.
14. Zaias N, Drachman D: A method for the determination of drug effectiveness in onychomycosis. J Am Acad Dermatol 9: 912-919, 1983.
15. Gupta AK, DeDoncker P, Scher RK, et al: Itraconazole for the treatment of onychomycosis: an overview. Int J Dermatol 37: 303-308, 1998.
16. Gupta AK, Scher RK: Management of onychomycosis: a North American perspective. In, Dermatology Therapy (Elewski BE, ed), 3: 58-65. Denmark, Munksgaard Press, 1997.
17. Zaias N, Tosti A, Rebell G, et al: Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol 34: 302-304, 1996.